Related Experiment Video
Updated: Jan 12, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Antivirulence drugs against Acinetobacter baumannii: where do they stand?
Aya A Elanany1, Amany G Khalifa2, Ahmed S Attia3
1Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
None:
Acinetobacter baumannii is a nosocomial Gram-negative pathogen of multi- and extensive-drug resistance phenotypes. In certain regions, multi-drug resistance rates can soar as high as 80-90%. Accordingly, reports by the World Health Organization and the Centers for Disease Control and Prevention underscore the urgent need for developing new antibiotics against A. baumannii. With the scarcity of novel antibiotics against this pathogen in the development pipeline, its rapid ability to develop and acquire resistance, and its versatile virulence weaponry, antivirulence therapeutics that can attenuate its virulence without adversely affecting growth may represent a promising treatment option with less selective pressure for resistance development. This review summarizes different antivirulence strategies against A. baumannii, which have been preclinically tested in various in vivo models. We also review different challenges and opportunities related to the realization of A. baumannii antivirulence drugs for clinical use.
More Related Videos
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
07:41Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
Published on: August 4, 2023
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute Pyelonephritis II: Diagnostic Studies and Management